AgeX Therapeutics (AGE) News Today → What’s Really Next for America… (From Porter & Company) (Ad) Free AGE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisEarningsHeadlinesOwnershipSocial MediaStock AnalysisEarningsHeadlinesOwnershipSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 7, 2024 | finance.yahoo.comStem Cell Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 162 Agreements Signed Since 2016March 26, 2024 | globenewswire.comSerina Therapeutics Announces Completion of Merger with AgeX TherapeuticsMarch 23, 2024 | finanznachrichten.deAgeX Therapeutics, Inc.: AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsMarch 22, 2024 | globenewswire.comAgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsMarch 18, 2024 | marketbeat.comAgeX Therapeutics (NYSE:AGE) Sees Unusually-High Trading VolumeAgeX Therapeutics (NYSE:AGE) Sees Strong Trading VolumeMarch 15, 2024 | marketbeat.comAgeX Therapeutics (NYSE:AGE) Reaches New 12-Month High at $17.42AgeX Therapeutics (NYSE:AGE) Sets New 1-Year High at $17.42February 27, 2024 | businesswire.comAGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGEFebruary 7, 2024 | msn.comAgeX Therapeutics Secures $500K Convertible Note DealFebruary 7, 2024 | msn.comAgeX Therapeutics Expands Ties with JuvVentures Equity DealJanuary 25, 2024 | msn.comWhy IBM Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving PremarketDecember 13, 2023 | morningstar.comAgeX Therapeutics Inc AGENovember 17, 2023 | msn.comWhat's Going On With Penny Stock AgeX Therapeutics?November 17, 2023 | finance.yahoo.comSerina Therapeutics Announces POZ Polymer Technology License Agreement with PfizerNovember 14, 2023 | msn.comAgeX Therapeutics GAAP EPS of -$0.14, revenue of $0.06MNovember 14, 2023 | finance.yahoo.comAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 6, 2023 | benzinga.comObesity Pipeline | Clinical Trials, Key Companies – Aardvark, Adocia, Agentix AgeX TherapeuticsAugust 31, 2023 | msn.comSerina Therapeutics to merge with subsidiary of AgeXAugust 30, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether AgeX Therapeutics, Inc. has obtained a Fair Price in its transaction with SerinaAugust 30, 2023 | seekingalpha.comSerina Therapeutics and Agex Therapeutics enter merger agreementAugust 30, 2023 | marketwatch.comAgeX Therapeutics Shares Rise Premarket on Reverse Merger Deal >AGEAugust 30, 2023 | finance.yahoo.comSerina Therapeutics and AgeX Therapeutics Enter into Merger AgreementAugust 14, 2023 | finance.yahoo.comAgeX Therapeutics Reports Second Quarter 2023 Financial ResultsJuly 24, 2023 | finance.yahoo.comAgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred StockJuly 21, 2023 | seekingalpha.comAgeX issues preferred stock to Juvenescence to nix $36M debtJune 28, 2023 | finance.yahoo.com25 States with the Highest Life Expectancy in the USMay 17, 2023 | finance.yahoo.comNYSE American to Suspend Trading Immediately in AgeX Therapeutics, Inc. (AGE) and Commence Delisting ProceedingsMay 17, 2023 | businesswire.comCORRECTING and REPLACING NYSE American to Commence Delisting Proceedings Against AgeX Therapeutics, Inc. (AGE)May 12, 2023 | seekingalpha.comAgeX Therapeutics GAAP EPS of -$0.09, revenue of $0.01MMay 12, 2023 | marketwatch.comAgeX Therapeutics Says Projected Cash Flows Raise Going Concern DoubtsMay 12, 2023 | finance.yahoo.comAgeX Therapeutics Reports First Quarter 2023 Financial ResultsMarch 31, 2023 | finance.yahoo.comAgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial ResultsMarch 30, 2023 | seekingalpha.comAGE AgeX Therapeutics, Inc.March 16, 2023 | msn.comTonix starts enrollment in mid-stage study of depression drug TNX-601 ERMarch 16, 2023 | msn.comAgeX Therapeutics gets $10M loan ahead of potential restructuringFebruary 21, 2023 | 247wallst.comJuvenescence Now Owns 75.60% of AgeX TherapeuticsFebruary 13, 2023 | marketwatch.comAnti-Senescence Therapy Market Industry Analysis Database for Period from 2023-2028December 22, 2022 | marketwatch.comWith 7.8% CAGR, Longevity and Anti-senescence Therapy Market to Witness A Pronounce Growth During 2023-2028 | 87 Pages ReportDecember 2, 2022 | marketwatch.comLongevity and Anti-senescence Therapy Market 2023 Expected to Reach Significant Rate by 2028November 25, 2022 | finance.yahoo.comAgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing RequirementsNovember 10, 2022 | finance.yahoo.comAgeX Therapeutics Reports Third Quarter 2022 Financial ResultsOctober 12, 2022 | marketwatch.comLongevity and Anti-senescence Therapy Market Analysis Research Report, Challenges, Scopes, Market Share, Revenue, and Forecasts 2022 to 2028September 12, 2022 | finance.yahoo.comAgeX Therapeutics, Inc. (AGE)August 14, 2022 | seekingalpha.comAgeX Therapeutics GAAP EPS of -$0.07, revenue of $0.01MAugust 14, 2022 | marketwatch.comAgeX Therapeutics Says Its Cash Position Raises Doubt About Continuing as a Going ConcernAugust 12, 2022 | finance.yahoo.comAgeX Therapeutics Reports Second Quarter 2022 Financial ResultsAugust 11, 2022 | forbes.comThe 9th ARDD: Longevity Biotechnology Is Gaining Prominence And Credibility In The Pharmaceutical IndustryMay 18, 2022 | finance.yahoo.comDr. Joanne Hackett Appointed Chairperson of AgeX Board of DirectorsMay 15, 2022 | seekingalpha.comAgeX Therapeutics GAAP EPS of -$0.07May 13, 2022 | finance.yahoo.comAgeX Therapeutics Reports First Quarter 2022 Financial ResultsApril 14, 2022 | uk.finance.yahoo.comGlobal Senolytic Drugs Market, By Type, By Application, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2017-2027 Get AgeX Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August… Click here now for my urgent election forecast. AGE Media Mentions By Week AGE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGE News Sentiment▼0.550.57▲Average Medical News Sentiment AGE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGE Articles This Week▼10▲AGE Articles Average Week Get AgeX Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMNN News ELAB News AKTX News MBRX News MIRA News ABVC News PPBT News KPRX News ERNA News MNPR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AGE) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AgeX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
